First technical workshop on the Good Distribution Practices (GDP) of medical products in the WHO European Region

27 - 29 January 2015, Hillerød, Denmark

The Health Technology and Pharmaceuticals (HTP) unit in WHO/Europe organized a Good Distribution Practice (GDP) workshop in Denmark in collaboration with the Danish health and medicines authority and the WHO Collaborating centre for drug policy and pharmacy practice development.

Good distribution practice is a fundamental component in ensuring access to quality, safe and effective medical products and globalization of supply chains brings a number of challenges to the pharmaceutical manufacturing and distribution industries and the National Medicines Regulatory Authorities (NMRA’S) regulating them. Ensuring that no weak links exist in the supply chain is critical in protecting patients from unsafe medical products. The risks posed by substandard, falsified, stolen and diverted medical products are well documented. Non-compliance with GDP by just one distributor can lead to a disproportionately large negative impact on public health, including a loss of public confidence in our health systems, health products and healthcare professionals. A well regulated supply chain is the best way of minimizing the risks from these types of products.